Goodwill in USD of BIO-TECHNE Corp from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
BIO-TECHNE Corp quarterly Goodwill history and change rate from Q2 2010 to Q3 2025.
  • BIO-TECHNE Corp Goodwill for the quarter ending 30 Sep 2025 was $979M, a 0.37% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $979M -$3.67M -0.37% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $981M +$8.27M +0.85% 30 Jun 2025 10-Q 05 Nov 2025
Q1 2025 $969M -$2.35M -0.24% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $965M -$15.5M -1.58% 31 Dec 2024 10-Q 06 Feb 2025
Q3 2024 $983M +$13.2M +1.36% 30 Sep 2024 10-Q 05 Nov 2024
Q2 2024 $973M +$99.9M +11.5% 30 Jun 2024 10-K 22 Aug 2025
Q1 2024 $971M +$100M +11.5% 31 Mar 2024 10-Q 06 May 2024
Q4 2023 $980M +$110M +12.7% 31 Dec 2023 10-Q 07 Feb 2024
Q3 2023 $969M +$104M +12% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 $873M +$50.6M +6.16% 30 Jun 2023 10-K 22 Aug 2025
Q1 2023 $871M +$42.9M +5.19% 31 Mar 2023 10-Q 08 May 2023
Q4 2022 $870M +$37.5M +4.51% 31 Dec 2022 10-Q 07 Feb 2023
Q3 2022 $865M +$22.4M +2.65% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $822M -$21M -2.49% 30 Jun 2022 10-K 22 Aug 2024
Q1 2022 $828M +$81.2M +10.9% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $832M +$104M +14.2% 31 Dec 2021 10-Q 07 Feb 2022
Q3 2021 $843M +$111M +15.2% 30 Sep 2021 10-Q 07 Feb 2022
Q2 2021 $843M +$115M +15.8% 30 Jun 2021 10-K 23 Aug 2023
Q1 2021 $746M +$20.6M +2.84% 31 Mar 2021 10-Q 07 May 2021
Q4 2020 $728M -$5.93M -0.81% 31 Dec 2020 10-Q 07 May 2021
Q3 2020 $732M +$1.22M +0.17% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $728M -$4.36M -0.6% 30 Jun 2020 10-K 24 Aug 2022
Q1 2020 $726M +$6.22M +0.87% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $734M +$27.9M +3.95% 31 Dec 2019 10-Q 06 Feb 2020
Q3 2019 $730M +$25.6M +3.64% 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $733M +$135M +22.5% 30 Jun 2019 10-K 25 Aug 2021
Q1 2019 $720M +$109M +17.8% 31 Mar 2019 10-Q 07 May 2019
Q4 2018 $706M +$117M +19.9% 31 Dec 2018 10-Q 07 Feb 2019
Q3 2018 $705M +$117M +19.9% 30 Sep 2018 10-Q 07 Nov 2018
Q2 2018 $598M +$18.9M +3.26% 30 Jun 2018 10-K 26 Aug 2020
Q1 2018 $611M +$40.9M +7.18% 31 Mar 2018 10-Q 09 May 2018
Q4 2017 $589M +$31.4M +5.63% 31 Dec 2017 10-Q 08 Feb 2018
Q3 2017 $588M +$22M +3.89% 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 $579M +$148M +34.4% 30 Jun 2017 10-K/A 06 Nov 2019
Q1 2017 $570M +$135M +31.1% 31 Mar 2017 10-Q 10 May 2017
Q4 2016 $558M +$134M +31.6% 31 Dec 2016 10-Q 09 Feb 2017
Q3 2016 $566M +$138M +32.4% 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 $431M +$40.2M +10.3% 30 Jun 2016 10-K 27 Aug 2018
Q1 2016 $435M +$48.9M +12.7% 31 Mar 2016 10-Q 10 May 2016
Q4 2015 $424M +$22.2M +5.54% 31 Dec 2015 10-Q 09 Feb 2016
Q3 2015 $427M +$122M +40% 30 Sep 2015 10-Q 09 Nov 2015
Q2 2015 $391M +$239M +158% 30 Jun 2015 10-K 07 Sep 2017
Q1 2015 $386M +$241M +167% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 $402M +$257M +178% 31 Dec 2014 10-Q 09 Feb 2015
Q3 2014 $305M +$161M +112% 30 Sep 2014 10-Q 10 Nov 2014
Q2 2014 $151M +$67.1M +79.6% 30 Jun 2014 10-K 29 Aug 2016
Q1 2014 $145M +$60.3M +71.6% 31 Mar 2014 10-Q 12 May 2014
Q4 2013 $144M +$57.2M +65.6% 31 Dec 2013 10-Q 04 Feb 2014
Q3 2013 $144M +$56.9M +65.4% 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 $84.3M -$1.35M -1.57% 30 Jun 2013 10-K 31 Aug 2015
Q1 2013 $84.3M -$2.21M -2.56% 31 Mar 2013 10-Q 10 May 2013
Q4 2012 $87.2M +$1.93M +2.26% 31 Dec 2012 10-Q 11 Feb 2013
Q3 2012 $86.9M +$1.58M +1.85% 30 Sep 2012 10-Q 09 Nov 2012
Q2 2012 $85.7M -$951K -1.1% 30 Jun 2012 10-K 29 Aug 2014
Q1 2012 $86.5M +$61.5M +245% 31 Mar 2012 10-Q 10 May 2012
Q4 2011 $85.2M +$60.2M +240% 31 Dec 2011 10-Q 07 Feb 2012
Q3 2011 $85.4M +$60.3M +241% 30 Sep 2011 10-Q 09 Nov 2011
Q2 2011 $86.6M +$61.6M +246% 30 Jun 2011 10-K 29 Aug 2013
Q1 2011 $25.1M 31 Mar 2011 10-Q 10 May 2011
Q4 2010 $25.1M 31 Dec 2010 10-Q 09 Feb 2011
Q3 2010 $25.1M 30 Sep 2010 10-Q 09 Nov 2010
Q2 2010 $25.1M 30 Jun 2010 10-K 29 Aug 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.